<DOC>
	<DOCNO>NCT01344148</DOCNO>
	<brief_summary>To determine best time begin anti-HIV ( Acquired Immunodeficiency Syndrome ) treatment individual co-infected HIV tuberculosis ( Tb ) . This prospective , randomize study conduct HIV/Tb co-infected patient China evaluate compare efficacy antiretroviral therapy 2 week TB treatment versus defer ART initiate 8 week initiation TB treatment .</brief_summary>
	<brief_title>Acquired Immunodeficiency Syndrome ( AIDS ) Tuberculosis ( Tb ) Co-infection Treatment Strategies Study China .</brief_title>
	<detailed_description>Anti-Tb Therapy : 2HREZ-4HRifb ( H : Isoniazid，R : Rifampicin，E : Ethambutol，Z：pyrazinamide，Rifb : Rifabutin ) HAART : The first line Zidovudine ( AZT ) +Lamivudine ( 3TC ) +Efavirenz ( EFV ) second line Stavudine ( D4T ) +3TC+EFV Study group one : anti-TB therapy 2 week begin High Active Antiretroviral Therapy ( HAART ) ; study group two : anti-TB therapy 8 week begin HAART . If begin HAART H change Rifb .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Coinfection</mesh_term>
	<criteria>Clinical diagnosis AIDS coinfected TB CD4 T cell count low 350/ul Must able swallow tablet finish followup Sign information consent form Chinese Can tolerance therapy estimate doctor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Anti- TB</keyword>
	<keyword>HAART</keyword>
	<keyword>choice right moment</keyword>
</DOC>